Anti-tumoral action of octreotide and bromocriptine on the experimental rat prolactinoma: Anti-proliferative and pro-apoptotic effects

Neuroendocrinology Letters

Volumn 22, Issue 5, 2001, Pages 343-348

  Gruszka, A ^a   Pawlikowski, M ^a   Kunert Radek, J ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Apoptosis; Bromocriptine; Experimental prolactinoma; Octreotide; Proliferation

Indexed keywords

BROMOCRIPTINE; BROXURIDINE; DIETHYLSTILBESTROL; DNA FRAGMENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; OCTREOTIDE; PROLACTIN; SOMATOSTATIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CELL LABELING; CELL NUCLEUS; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; EXPERIMENTAL RAT; HORMONE INHIBITION; MALE; NICK END LABELING; NONHUMAN; PROLACTIN RELEASE; PROLACTINOMA; RADIOIMMUNOASSAY; RAT; RAT STRAIN; TUMOR CELL; TUMOR VOLUME;

EID: 0034754309     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors
2. Bromocriptine treatment reduces the cell size in human macroprolactinomas: A morphometric study
3. Neurotransmitter control of adenohypophysial cell proliferation
4. The effect of mesulergine on prolactin secretion and anterior pituitary cells morphology in diethylstilboestrol-treated female Wistar rats
5. D2 dopamine-receptor-mediated inhibition of proliferation of rat lactotropes in culture is accompanied by changes in cell shape
6. In vivo effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors
7. Inhibitory effects of dopamine agonists quinagolide (CV 205-502) and bromocriptine on prolactin secretion and growth of SMtTW pituitary tumors in the rat
8. Macroprolactinoma size reduction with dopamine agonists
9. Diagnosis and treatment of pituitary tumors
10. Inhibition of growth of a prolactin-secreting pituitary tumor in rats by analog luteinizing hormone-releasing hormone and somatostatin
11. The effect of somatostatin analog octreotide on diethyl-stilboestrol-induced prolactin secretion, cell proliferation and vascular changes in the rat anterior pituitary gland
12. Relative potencies of the somatostatin analogs octreotide, BIM-23014 and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells
13. Somatostatin-14 and its analog octreotide exert a cytostatic effect on GH3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block
14. Apoptosis in non-tumorous and neoplastic human pituitaries. Expression of the Bcl-2 family of proteins
15. Apoptosis and p53 suppressor gene protein expression in human anterior pituitary adenoma
16. Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors. Comparison between micro- and macroadenomas
17. Apoptosis in the anterior pituitary gland of the rat: Studies with estrogen and bromocriptine
18. Induction of apoptosis in cells of GH3 line by bromocriptine
19. Cell cycle dependent induction of apoptosis by somatostatin analog SMS 201-995 in AtT-20 mouse pituitary cells
20. Absence of apoptosis in somatropinomas treated with octreotide
21. A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzmann rats
22. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
23. Somatostatin does not inhibit prolactin synthesis in normal male rat pituitary cells but inhibits prolactin synthesis in estradiol-primed pituitary cells
24. Effect of 17β-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures
25. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas
26. Effect of the slow-release formulation of somatuline (BIM 23014) on estrogen-induced hyperprolactinaemia and lactotroph hyperplasia in the female rat
27. Effects of oestrogen and bromocryptine on in vitro secretion and mitosis in prolactin cells
28. Effects of pimozide and bromocriptine on anterior pituitary cell proliferation
29. Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumor
30. Effects of bromocriptine and terguride on cell proliferation and apoptosis in the estrogen-stimulated anterior pituitary gland of the rat
31. Apoptoza w leczeniu guźow przysadki typu somato-tropinoma i prolactinoma
32. Subtype-selective induction of wild type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3
33. Wykrywanie mRNA szczurzego receptora dla somatostatyny typu 2 (SSTR-2 mRNA) metoda nieizotopowej hybrydyzacji in situ
34. A comparison of octreotide, bromocriptine, or a combination of both drugs in acromegaly